Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gent

Showing results (81-90 of 242) with videos related to

Pageof 25
Sort By:
Stroke|January 1, 1977
XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapyE Genton, H J Barnett, W S Fields, et al.
Thrombosis and Haemostasis|November 24, 1989
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacementM N Levine, A Planes, J Hirsh, et al.
Archives of Internal Medicine|May 7, 1998
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Circulation|September 1, 1975
The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosisA Kaegi, G F Pineo, A Shimizu, et al.
Chest|September 3, 1998
The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Canadian Medical Association Journal|January 5, 1974
Intra-uterine infection and cord immunoglobulin M. II. Clinical analysis of infants with elevated cord serum immunoglobulin MA Finkel, P B Dent, W H Emrich, et al.
The New England Journal of Medicine|February 7, 1974
Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazoneA Kaegi, G F Pineo, A Shimizu, et al.
The New England Journal of Medicine|June 30, 1988
Colchicine in the treatment of cirrhosis of the liverD Kershenobich, F Vargas, G Garcia-Tsao, et al.
The Journal of Rheumatology|June 1, 1997
Interaction between cyclosporin A and nonsteroidal antiinflammatory drugsP Tugwell, D Ludwin, M Gent, et al.
Thrombosis and Haemostasis|February 12, 1998
The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort studyR Rajan, M Levine, M Gent, et al.
Pageof 25

Showing results (81-90 of 242) with videos related to

Sort By:
Pageof 25
Stroke|January 1, 1977
XIV. Cerebral ischemia: the role of thrombosis and of antithrombotic therapy. Study group on antithrombotic therapyE Genton, H J Barnett, W S Fields, et al.
Thrombosis and Haemostasis|November 24, 1989
The relationship between anti-factor Xa level and clinical outcome in patients receiving enoxaparine low molecular weight heparin to prevent deep vein thrombosis after hip replacementM N Levine, A Planes, J Hirsh, et al.
Archives of Internal Medicine|May 7, 1998
The incidence of symptomatic venous thromboembolism during and after prophylaxis with enoxaparin: a multi-institutional cohort study of patients who underwent hip or knee arthroplasty. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Circulation|September 1, 1975
The role of sulfinpyrazone in the prevention of arterio-venous shunt thrombosisA Kaegi, G F Pineo, A Shimizu, et al.
Chest|September 3, 1998
The incidence of symptomatic venous thromboembolism after enoxaparin prophylaxis in lower extremity arthroplasty: a cohort study of 1,984 patients. Canadian Collaborative GroupJ R Leclerc, M Gent, J Hirsh, et al.
Canadian Medical Association Journal|January 5, 1974
Intra-uterine infection and cord immunoglobulin M. II. Clinical analysis of infants with elevated cord serum immunoglobulin MA Finkel, P B Dent, W H Emrich, et al.
The New England Journal of Medicine|February 7, 1974
Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazoneA Kaegi, G F Pineo, A Shimizu, et al.
The New England Journal of Medicine|June 30, 1988
Colchicine in the treatment of cirrhosis of the liverD Kershenobich, F Vargas, G Garcia-Tsao, et al.
The Journal of Rheumatology|June 1, 1997
Interaction between cyclosporin A and nonsteroidal antiinflammatory drugsP Tugwell, D Ludwin, M Gent, et al.
Thrombosis and Haemostasis|February 12, 1998
The occurrence of subsequent malignancy in patients presenting with deep vein thrombosis: results from a historical cohort studyR Rajan, M Levine, M Gent, et al.
Pageof 25